Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 3fludarabine 2Paclitaxel 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1pembrolizumab 1olaparib 1niraparib 1mirvetuximab soravtansine 1irinotecan sucrosofate 1fludarabine phosphate 1denileukin diftitox 1Tinzaparin 1Propranolol 1Palliative Care 1Nivolumab 1Neoadjuvant Therapy 1Music Therapy 1Losartan 1Indocyanine Green 1GEN-1 1Etodolac 1E7777 fusion protein 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Tinzaparin × 30 days × Clear all
NCT05284552 2026-05-11

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

University Hospital, Linkoeping

Phase 2 Recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡